Transverse Myelitis - Causes, Treatment & When to See a Doctor

```html

What is Transverse Myelitis?

Transverse myelitis (TM) is an inflammatory disorder that damages a segment of the spinal cord. The inflammation compresses, scars, or destroys nerve fibers, disrupting the transmission of neural signals between the brain and the body. The term “transverse” refers to the fact that the inflammation typically spreads across the width of the spinal cord, affecting both sides (right and left) at a particular level.

Patients often experience a rapid onset of neurological symptoms—such as weakness, sensory loss, and autonomic dysfunction—that develop over minutes to several days. Although TM can affect anyone, it most commonly appears in adolescents and young adults, and it may be a one‑time event or recur as part of a chronic neurological condition.

Because the spinal cord controls movement, sensation, and many involuntary functions (bladder, bowel, and sexual function), even a short lesion can have a profound impact on daily life. Early recognition and treatment are essential to limit permanent disability.

Common Causes

Transverse myelitis is usually a secondary manifestation of another disease or trigger. The following 10 conditions are the most frequently associated with TM:

• Post‑infectious immune response – after viral infections such as influenza, Epstein‑Barr virus, COVID‑19, or herpes simplex.
• Autoimmune diseases – multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), systemic lupus erythematosus, and Sjögren’s syndrome.
• Vaccinations – rarely, vaccines (e.g., influenza, hepatitis B, or COVID‑19) can trigger an aberrant immune reaction.
• Paraneoplastic syndromes – immune responses to cancers such as lymphoma, breast, or lung cancer.
• Idiopathic – no identifiable cause; about 20–30 % of cases fall into this category.
• Infectious agents (direct invasion) – bacterial (e.g., syphilis, Lyme disease), viral (e.g., West Nile virus, HIV), or parasitic (e.g., schistosomiasis).
• Systemic inflammatory disorders – sarcoidosis or vasculitis (e.g., Behçet’s disease).
• Drug‑induced – certain medications, such as some antibiotics (e.g., minocycline) or chemotherapy agents, have been implicated.
• Radiation myelopathy – delayed spinal cord injury after therapeutic radiation.
• Genetic/metabolic conditions – rare metabolic storage diseases (e.g., adrenoleukodystrophy) can mimic or precipitate TM.

Associated Symptoms

The clinical picture varies with the level of the spinal cord that is inflamed, but several symptoms appear together in most patients:

• Motor weakness – often beginning in the legs and progressing upward; may be asymmetric.
• Sensory disturbances – numbness, tingling, or a “pins‑and‑needles” sensation on both sides of the body below the lesion.
• Pain – sharp or aching back pain at the level of inflammation, sometimes radiating to the limbs.
• Bladder dysfunction – urgency, frequency, retention, or incontinence.
• Bowel dysfunction – constipation or loss of control.
• Sphincter/sexual dysfunction – difficulty with ejaculation, erectile dysfunction, or loss of vaginal lubrication.
• Autonomic instability – abnormal blood pressure or heart‑rate fluctuations.
• Spasticity – muscle stiffness or involuntary jerks (especially during recovery).

Symptoms typically evolve over a period of hours to a few days, reach a “plateau” phase (usually within 2–4 weeks), and then enter a recovery phase that can last months to years.

When to See a Doctor

Because TM can progress quickly and lead to permanent neurologic damage, prompt medical evaluation is crucial. Seek care if you notice any of the following:

• Rapidly worsening weakness in the arms or legs.
• New loss of sensation (numbness, tingling) that spreads downward from the torso.
• Severe, unrelenting back pain that does not improve with rest or over‑the‑counter pain relievers.
• Difficulty starting or stopping urination, or a feeling of incomplete bladder emptying.
• Sudden onset of bowel incontinence.
• Fever or recent infection followed by neurologic changes.

If any of these signs appear, go to an emergency department or call emergency services immediately. Early treatment can reduce inflammation and improve long‑term outcomes.

Diagnosis

Diagnosing transverse myelitis involves a combination of clinical assessment, imaging, laboratory testing, and sometimes lumbar puncture. The goal is to confirm spinal cord inflammation, locate the lesion, identify the underlying cause, and rule out mimicking conditions such as spinal cord compression or stroke.

1. Clinical Neurologic Examination

The physician evaluates muscle strength, reflexes, sensation, coordination, and autonomic function. The pattern of deficits (e.g., a “sensory level” where sensation changes) helps pinpoint the spinal segment involved.

2. Magnetic Resonance Imaging (MRI)

• Spinal cord MRI with gadolinium contrast is the gold standard. It typically shows a focal, longitudinally extensive lesion (often >3 vertebral segments) with enhancement indicating active inflammation.
• MRI of the brain may be performed to exclude demyelinating diseases like multiple sclerosis.

3. Lumbar Puncture (Spinal Fluid Analysis)

• Elevated white‑blood‑cell count (pleocytosis) and increased protein suggest inflammation.
• Testing for oligoclonal bands, IgG index, and specific pathogens (e.g., HSV, VZV, SARS‑CoV‑2) helps differentiate causes.

4. Blood Tests

• Complete blood count, inflammatory markers (ESR, CRP), and metabolic panel.
• Autoimmune panel: ANA, anti‑dsDNA, anti‑SSA/SSB, AQP4 antibody (for NMOSD), MOG antibody.
• Infectious serologies: HIV, syphilis, Lyme, West Nile, COVID‑19 PCR/antigen.

5. Additional Studies

• Evoked potentials to assess conduction speed.
• Chest X‑ray or CT if sarcoidosis or malignancy is suspected.

Treatment Options

Therapy focuses on three goals: (1) halt the inflammatory process, (2) support neurological recovery, and (3) manage complications.

1. Acute Anti‑inflammatory Therapy

• Corticosteroids – Intravenous methylprednisolone 1 g daily for 3–5 days is the first‑line treatment. It reduces swelling and immune activity.
• Plasma exchange (PLEX) – Considered when patients do not improve after steroids, especially in NMOSD or severe cases.
• Intravenous immunoglobulin (IVIG) – May be used for idiopathic or post‑infectious TM when steroids are contraindicated.

2. Disease‑Specific Therapy

• If an underlying infection is identified, appropriate antimicrobial therapy (e.g., antibiotics for Lyme disease, antiviral agents for HSV) is initiated.
• For autoimmune causes (MS, NMOSD, lupus), disease‑modifying agents such as rituximab, mycophenolate mofetil, or disease‑specific monoclonal antibodies are added after the acute phase.

3. Rehabilitation & Supportive Care

• Physical therapy – early mobilization, gait training, and strengthening exercises prevent contractures and improve function.
• Occupational therapy – assists with activities of daily living, adaptive equipment, and home modifications.
• Speech & swallowing evaluation – needed if high cervical lesions affect breathing or swallowing.
• Bladder & bowel programs – intermittent catheterization, bowel regimens, and pelvic floor therapy.
• Pain management – neuropathic pain agents (gabapentin, pregabalin) plus non‑opioid analgesics.

4. Home‑Based Strategies

• Maintain a balanced diet rich in protein, omega‑3 fatty acids, and antioxidants to support nerve healing.
• Stay well‑hydrated; adequate fluid intake helps bladder function.
• Use a night‑time urinary alarm or scheduled voiding to reduce incontinence.
• Apply heat or cold packs to painful areas as tolerated.
• Practice deep‑breathing and gentle stretching to reduce spasticity.

Prevention Tips

Because many cases of TM are triggered by infections or autoimmune activity, complete prevention is impossible, but several measures can lower risk:

• Vaccination – Stay up‑to‑date with recommended vaccines (influenza, COVID‑19, varicella, hepatitis B) to lessen severe infections that may precipitate TM.
• Infection control – Practice hand hygiene, avoid sharing personal items, and seek prompt treatment for infections (especially respiratory or gastrointestinal).
• Manage chronic autoimmune disease – Consistent follow‑up with a rheumatologist or neurologist and adherence to disease‑modifying therapy reduces flare‑ups that could involve the spinal cord.
• Healthy lifestyle – Regular exercise, adequate sleep, stress reduction, and a Mediterranean‑style diet support overall immune regulation.
• Avoid known drug triggers – Discuss any new medication with your physician, especially if you have a history of TM.

Emergency Warning Signs

Key Take‑aways

• Transverse myelitis is an inflammatory spinal‑cord condition that can cause rapid weakness, sensory loss, and autonomic dysfunction.
• It is most often triggered by infections, autoimmune diseases, or, less frequently, by vaccines and drugs.
• Prompt medical evaluation—including MRI, spinal‑fluid analysis, and blood tests—is essential to confirm the diagnosis and identify the cause.
• High‑dose steroids are first‑line therapy; plasma exchange or IVIG are options when steroids fail.
• Comprehensive rehabilitation and supportive care are crucial for functional recovery.
• Patients should seek urgent care for any sudden neurologic decline, bladder or bowel problems, or severe pain.

For further reading and up‑to‑date guidelines, see resources from the Mayo Clinic, CDC, and the National Institute of Neurological Disorders and Stroke (NINDS).

```